IPP Bureau
Omega Healthcare to expand operations in India
By IPP Bureau - May 10, 2022
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
Bora Pharmaceuticals acquires Eden Biologics CDMO assets
By IPP Bureau - May 10, 2022
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine
By IPP Bureau - May 10, 2022
CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
By IPP Bureau - May 10, 2022
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Glenmark receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate
By IPP Bureau - May 09, 2022
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
InxMed raises US $ 15 million in Series B+ financing
By IPP Bureau - May 09, 2022
The plan is to advance innovative therapies to drug-resistant cancers
ExoCoBio receives Japanese patent for alleviating dermatitis
By IPP Bureau - May 09, 2022
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
By IPP Bureau - May 09, 2022
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Strengthening the access to rare disease treatment in India
By IPP Bureau - May 09, 2022
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
By IPP Bureau - May 09, 2022
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
By IPP Bureau - May 09, 2022
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds
By IPP Bureau - May 09, 2022
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
Mylab appoints Rajesh Patel as the Executive Director of In-Vitro Diagnostics Business
By IPP Bureau - May 09, 2022
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
Premas Biotech appoints Saumen Chakraborty to its Board
By IPP Bureau - May 09, 2022
Saumen is a postgraduate in management from IIM, Ahmedabad and an executive fellow in management from ISB, Hyderabad
Aadi Bioscience announces collaborations with next generation sequencing leaders
By IPP Bureau - May 09, 2022
The company enters into collaborations with leading next-generation sequencing (NGS) companies to facilitate trial enrollment for PRECISION 1, the Company’s Phase 2 registrational trial
